✦ LIBER ✦

Outcome of peptide receptor radionuclide therapy with177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours

✍ Scribed by Ezziddin, Samer; Khalaf, Feras; Vanezi, Maria; Haslerud, Torjan; Mayer, Karin; Al Zreiqat, Abdullah; Willinek, Winfried; Biersack, Hans-Jürgen; Sabet, Amir

Book ID: 121556158
Publisher: Springer
Year: 2014
Tongue: English
Weight: 462 KB
Volume: 41
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-013-2677-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peptide receptor radionuclide therapy wi

Peptide receptor radionuclide therapy with177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin

✍ Martijn van Essen; Eric P. Krenning; Willem H. Bakker; Wouter W. de Herder; Maar 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 269 KB

Outcome and toxicity of salvage therapy

Outcome and toxicity of salvage therapy with177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours

✍ Sabet, Amir; Haslerud, Torjan; Pape, Ulrich-Frank; Sabet, Amin; Ahmadzadehfar, H 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 254 KB

6605 POSTER Phase l-ll Study of Radiopep

6605 POSTER Phase l-ll Study of Radiopeptide 177 Lu-octreotate in Combination With Capecitabine and Temozolomide in Advanced Low-grade Neuroendocrine Tumours

✍ Claringbold, P.; Brayshaw, P.; Price, R.; Turner, J.H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Comparison of sequential planar177Lu-DOT

Comparison of sequential planar177Lu-DOTA-TATE dosimetry scans with68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy

✍ Aurora Sainz-Esteban; Vikas Prasad; Christiane Schuchardt; Carolin Zachert; José 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 444 KB